nitrendipine has been researched along with Obesity in 9 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combination therapy of nitrendipine and atenolol may significantly increase BW and fasting BG in overweight or obese patients with hypertension." | 9.14 | Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients. ( Qin, YW; Qiu, JL; Zhang, JL; Zhao, XX; Zheng, X; Zou, DJ, 2009) |
| "Combination therapy of nitrendipine and atenolol may significantly increase BW and fasting BG in overweight or obese patients with hypertension." | 5.14 | Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients. ( Qin, YW; Qiu, JL; Zhang, JL; Zhao, XX; Zheng, X; Zou, DJ, 2009) |
| "Nitrendipine treatment 1) lowered fasting serum insulin from 265 +/- 24 to 194 +/- 22 pmol/L (P < 0." | 2.67 | Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men. ( Arocha, IR; Beer, NA; Beer, RM; Jakubowicz, DJ; Nestler, JE, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, JL | 1 |
| Zheng, X | 1 |
| Zou, DJ | 1 |
| Qiu, JL | 1 |
| Zhao, XX | 1 |
| Qin, YW | 1 |
| Zawalich, WS | 1 |
| Tesz, GJ | 1 |
| Zawalich, KC | 1 |
| Beer, NA | 1 |
| Jakubowicz, DJ | 1 |
| Beer, RM | 1 |
| Arocha, IR | 1 |
| Nestler, JE | 1 |
| Draznin, B | 2 |
| Jones, BH | 1 |
| Kim, JH | 1 |
| Zemel, MB | 1 |
| Woychik, RP | 1 |
| Michaud, EJ | 1 |
| Wilkison, WO | 1 |
| Moustaid, N | 1 |
| Zhou, YP | 1 |
| Cockburn, BN | 1 |
| Pugh, W | 1 |
| Polonsky, KS | 1 |
| Byyny, RL | 1 |
| LoVerde, M | 1 |
| Lloyd, S | 1 |
| Mitchell, W | 1 |
| Valensi, P | 2 |
| Uzzan, B | 2 |
| Attali, JR | 2 |
| Perret, G | 2 |
| Vassy, R | 1 |
1 review available for nitrendipine and Obesity
| Article | Year |
|---|---|
Cytosolic calcium and insulin resistance.
Topics: Animals; Calcium; Humans; Hypertension; Insulin Resistance; Nitrendipine; Obesity | 1993 |
4 trials available for nitrendipine and Obesity
| Article | Year |
|---|---|
Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Body Mass Index | 2009 |
Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.
Topics: Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Dehydroepiandrosterone; Dehydroepiandros | 1993 |
Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Double-Blind Method; Female; Humans; Hyperten | 1991 |
Effect of nifedipine and nitrendipine on insulin release in non-diabetic obese patients: a double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Glucose; Humans; Insulin; Insulin Secretion; M | 1991 |
4 other studies available for nitrendipine and Obesity
| Article | Year |
|---|---|
Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice.
Topics: Analysis of Variance; Androstadienes; Animals; Blotting, Western; Calcium Channel Blockers; Cells, C | 2002 |
Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity.
Topics: Adipocytes; Agouti Signaling Protein; Animals; Cell Line; Fatty Acid Synthases; Female; Gene Express | 1996 |
Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Topics: Animals; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus; Diazoxide; Enzyme Inhibitors; G | 1999 |
Cytosolic calcium and insulin resistance in elderly patients with essential hypertension.
Topics: Adipose Tissue; Aged; Aging; Blood Glucose; Calcium; Cytosol; Deoxyglucose; Glucose Tolerance Test; | 1992 |